Journal of Current Medical Research and Opinion http://cmro.in/index.php/jcmro <p data-start="240" data-end="661">The <em data-start="244" data-end="301">Journal of Current Medical Research and Opinion (JCMRO)</em> is an international, peer-reviewed, open-access journal dedicated to publishing high-quality research in the field of medical and health sciences. The journal aims to promote the dissemination of scientifically sound and clinically relevant knowledge that contributes to the advancement of healthcare, biomedical research, and evidence-based medical practice.</p> <p data-start="663" data-end="1037">JCMRO provides a platform for researchers, clinicians, and academicians to share innovative findings, critical analyses, and emerging perspectives across a wide range of medical disciplines. The journal adheres to internationally recognized standards of publication ethics, following the guidelines of COPE and ICMJE, and ensures a rigorous double-blind peer review process.</p> <h1 data-section-id="1jm1vl" data-start="1044" data-end="1071"><span role="text"><strong data-start="1049" data-end="1071">Aim of the Journal</strong></span></h1> <p data-start="1073" data-end="1104">The primary aim of JCMRO is to:</p> <ul data-start="1105" data-end="1411"> <li data-section-id="1jvqtjf" data-start="1105" data-end="1195"> <p data-start="1107" data-end="1195">Publish original and impactful research that advances clinical and biomedical sciences</p> </li> <li data-section-id="tb3j1c" data-start="1196" data-end="1270"> <p data-start="1198" data-end="1270">Support evidence-based medical practice and healthcare decision-making</p> </li> <li data-section-id="1pr7drq" data-start="1271" data-end="1338"> <p data-start="1273" data-end="1338">Encourage interdisciplinary research and innovation in medicine</p> </li> <li data-section-id="1wcrfq0" data-start="1339" data-end="1411"> <p data-start="1341" data-end="1411">Provide a global platform for researchers, clinicians, and educators</p> </li> </ul> <p> </p> <h1 data-section-id="ee3n0s" data-start="1418" data-end="1447"><span role="text"><strong data-start="1423" data-end="1447">Scope of the Journal</strong></span></h1> <p data-start="1449" data-end="1522">JCMRO welcomes submissions from, but not limited to, the following areas:</p> <h3 data-section-id="11hwvtj" data-start="1524" data-end="1552"><span role="text"><strong data-start="1531" data-end="1552">Clinical Sciences</strong></span></h3> <ul data-start="1553" data-end="1687"> <li data-section-id="1hw3y97" data-start="1553" data-end="1574"> <p data-start="1555" data-end="1574">Internal Medicine</p> </li> <li data-section-id="5ajhj" data-start="1575" data-end="1589"> <p data-start="1577" data-end="1589">Cardiology</p> </li> <li data-section-id="1kzggja" data-start="1590" data-end="1603"> <p data-start="1592" data-end="1603">Neurology</p> </li> <li data-section-id="9obxko" data-start="1604" data-end="1616"> <p data-start="1606" data-end="1616">Oncology</p> </li> <li data-section-id="1nvgbsc" data-start="1617" data-end="1634"> <p data-start="1619" data-end="1634">Endocrinology</p> </li> <li data-section-id="1uwc6vi" data-start="1635" data-end="1655"> <p data-start="1637" data-end="1655">Gastroenterology</p> </li> <li data-section-id="zunodb" data-start="1656" data-end="1671"> <p data-start="1658" data-end="1671">Pulmonology</p> </li> <li data-section-id="1s0abip" data-start="1672" data-end="1687"> <p data-start="1674" data-end="1687">Dermatology</p> </li> </ul> <h3 data-section-id="1ql3tau" data-start="1689" data-end="1738"><span role="text"><strong data-start="1696" data-end="1738">Biomedical and Pharmaceutical Sciences</strong></span></h3> <ul data-start="1739" data-end="1890"> <li data-section-id="v4uh2m" data-start="1739" data-end="1770"> <p data-start="1741" data-end="1770">Pharmacology and Toxicology</p> </li> <li data-section-id="dptxlm" data-start="1771" data-end="1792"> <p data-start="1773" data-end="1792">Clinical Pharmacy</p> </li> <li data-section-id="rqzm6g" data-start="1793" data-end="1826"> <p data-start="1795" data-end="1826">Drug Development and Delivery</p> </li> <li data-section-id="d8d44a" data-start="1827" data-end="1866"> <p data-start="1829" data-end="1866">Biotechnology and Molecular Biology</p> </li> <li data-section-id="hbign6" data-start="1867" data-end="1890"> <p data-start="1869" data-end="1890">Medicinal Chemistry</p> </li> </ul> <h3 data-section-id="10koavr" data-start="1892" data-end="1943"><span role="text"><strong data-start="1899" data-end="1943">Public Health and Allied Health Sciences</strong></span></h3> <ul data-start="1944" data-end="2058"> <li data-section-id="1rpui3n" data-start="1944" data-end="1960"> <p data-start="1946" data-end="1960">Epidemiology</p> </li> <li data-section-id="jujnq7" data-start="1961" data-end="1983"> <p data-start="1963" data-end="1983">Community Medicine</p> </li> <li data-section-id="1oh4j4o" data-start="1984" data-end="2007"> <p data-start="1986" data-end="2007">Preventive Medicine</p> </li> <li data-section-id="1psaem7" data-start="2008" data-end="2025"> <p data-start="2010" data-end="2025">Global Health</p> </li> <li data-section-id="nwujyk" data-start="2026" data-end="2058"> <p data-start="2028" data-end="2058">Health Policy and Management</p> </li> </ul> <h3 data-section-id="1ye0m26" data-start="2060" data-end="2107"><span role="text"><strong data-start="2067" data-end="2107">Emerging and Interdisciplinary Areas</strong></span></h3> <ul data-start="2108" data-end="2275"> <li data-section-id="30e8dm" data-start="2108" data-end="2134"> <p data-start="2110" data-end="2134">Translational Medicine</p> </li> <li data-section-id="rvxysj" data-start="2135" data-end="2162"> <p data-start="2137" data-end="2162">Evidence-Based Medicine</p> </li> <li data-section-id="a9eybm" data-start="2163" data-end="2197"> <p data-start="2165" data-end="2197">Medical Education and Training</p> </li> <li data-section-id="ra0srd" data-start="2198" data-end="2233"> <p data-start="2200" data-end="2233">Digital Health and Telemedicine</p> </li> <li data-section-id="1smjdat" data-start="2234" data-end="2275"> <p data-start="2236" data-end="2275">Artificial Intelligence in Healthcare</p> </li> </ul> <h1 data-section-id="1ll39le" data-start="2282" data-end="2318"> </h1> <h1 data-section-id="1ll39le" data-start="2282" data-end="2318"><span role="text"><strong data-start="2287" data-end="2318">Types of Articles Published</strong></span></h1> <ul data-start="2319" data-end="2489"> <li data-section-id="1peju2n" data-start="2319" data-end="2349"> <p data-start="2321" data-end="2349">Original Research Articles</p> </li> <li data-section-id="12oswn9" data-start="2350" data-end="2369"> <p data-start="2352" data-end="2369">Review Articles</p> </li> <li data-section-id="1bulq9q" data-start="2370" data-end="2410"> <p data-start="2372" data-end="2410">Systematic Reviews and Meta-Analyses</p> </li> <li data-section-id="1n4cyed" data-start="2411" data-end="2443"> <p data-start="2413" data-end="2443">Case Reports and Case Series</p> </li> <li data-section-id="1tue089" data-start="2444" data-end="2468"> <p data-start="2446" data-end="2468">Short Communications</p> </li> <li data-section-id="ririm" data-start="2469" data-end="2489"> <p data-start="2471" data-end="2489">Clinical Studies</p> </li> </ul> <p data-start="2544" data-end="2795"> </p> en-US editor@cmro.in (Edwin Jarald) daga@cmro.in (Gaurav Daga) Mon, 18 May 2026 14:46:52 +0000 OJS 3.3.0.15 http://blogs.law.harvard.edu/tech/rss 60 Antioxidant (Superoxide and Hydroxyl Radical Scavenging), Antidiabetic Potential and Bioactive Chemical Properties of Celery (Apium graveolens) http://cmro.in/index.php/jcmro/article/view/1179 <p>Celery plant, which is also called Apium graveolens Linn, is an Asian plant that belongs to the family of Apiaceae. It can also be used to make many other things that include oil, fresh herbs, seeds and stalks, used in cooking and medicine. Phytochemical studies revealed the presence of numerous phytochemicals including, steroids, flavonoids in addition to vitamins A and C. The essential oils, leaves and seeds of the plant are used in traditional medicine. The paper aimed to discuss bioactive chemical properties and antioxidant activity of celery (Apium graveolens) and its use as an antidiabetic. The compounds present in the methanol extract identified by GC-mass analysis were 1-Pyrenehexadecanoicacid, Cyclohexanol, t-Butyltrifluoroacetate D-Ascorbic acid, 7Z,10Z-hexadecadienoic acid, N-Methyl-N-benzyltetradecanamine, oleic acid, 1-(trifluoromethyl) Cyclopropanemethanol, n-Hexadecanoic acid methyl ester, Butyric acid, 2-tridecyl ester, Butyric acid, 2-tridecyl ester, Phytol oleate, 9,12-Octadecadienoic acid, and cinnamaldehyde. The crude methanolic extract, ethyl acetate fraction, ethanol fraction, and celery (Apium graveolens) standards all demonstrated antioxidant potential, specifically in terms of superoxide radical scavenging, with values of (153.00±4.71, 109.45±5.53, 181.00±6.80, and 572.19±19.00, respectively). The results of hydroxyl radical scavenging were obtained as follows: (21.08±1.04, 27.00±1.46, 25.65±1.40 Quercetin (standard), and 572.19±19.00 respectively). The greatest dose that was studied produced the strongest inhibition, whereas the lowest amount produced the weakest. The inhibitory potency against α-amylase was measured to be (87.01±4.06, 31.00±2.05, 49.68±2.75, and 16.00±1.03) according to the kind of celery extract (Crude methanolic extract), ethyl acetate fraction, ethanol fraction, and acarbose (Standard), respectively. α-Glucosidase activity was measured as follows: (61.94±3.07, 42.81±2.15, 30.45±2.03, and 07.96±0.65, respectively).</p> Azhar A. Mhaibes , Nafal Nazar Bahjat, Ali Zeyad Al-Nuaimi Copyright (c) 2026 https://creativecommons.org/licenses/by/4.0 http://cmro.in/index.php/jcmro/article/view/1179 Mon, 18 May 2026 00:00:00 +0000 Hepatoprotective Effect of An Aqueous Extract of Rosmarinus officinalis Against Paracetamol-Induced Hepatotoxicity in Male Albino Rats http://cmro.in/index.php/jcmro/article/view/1181 <p>Background: Because it induces oxidative stress and the loss of cellular glutathione, acetaminophen (paracetamol) is still a leading cause of drug-induced liver injury (DILI) worldwide. Further investigations are required to prove the unique hepatoprotective effect of the aqueous extract of the medicinal plant Rosmarinus officinalis (Rosemary) on Paracetamol toxicity. Rosemary is well-known for its antioxidant properties. Objective: To find out if an aqueous extract of Rosmarinus officinalis can protect male albino rats from hepatotoxicity. Methods: One hundred twenty-four rats aged 13-14 weeks and weighing from 225-250 grams were used for the research. There were 6 rats per each of 4 groups. G1, the control group that did not receive any treatment, was the first one. The second group G2 was the control group who were given 25 mg/kg of paracetamol. The third group (G3) was treated with aqueous rosemary extract (200 mg/kg). The oral dose of Paracetamol (25 mg/kg) was given to each group every 2 hours after giving an aqueous extract (200 mg/kg) in Group 4 (control group). All oral administration was made through the gavage tube in the 60 day trial. Results: When paracetamol was dosed, there was a significant reduction (P ≤ 0.05) in average GSH and CAT levels and significant rise (P ≤ 0.05) in average MDA, ALT, and ALP levels as well as significant increase in the liver impairment score, indicating that this group was better than the control group. In the control group, no significant difference was found between the levels of AST, ALT and ALP at 200 mg/kg ROAE. With 200 mg/kg ROAE+25 mg Paracetamol group, however, there was a significant decrease in AST, ALT and ALP when compared with Paracetamol group. This indicates antioxidant and enzyme activity has been restored to normal level after pre-treatment with the aqueous rosemary extract. The significant increase in GSH and CAT levels and the significant decrease in MDA levels in the ROAE + paracetamol group when compared with the control group indicated that there was a remarkable improvement in the activity of these antioxidant enzymes. Histological examination showed that significant cell infiltration and central tubule degradation were present in the group receiving paracetamol. On the other hand, the groups that were given rosemary showed significant improvement. Preserved hepatocyte morphology, decreased necrotic areas and minimal inflammatory response indicated a strong regenerative response. Conclusion: Based on its bioactive component content, which helped stabilize metabolism and neutralize hepatocyte membrane, the study found that the aqueous rosemary extract had a hepatoprotective effect against paracetamol injury.</p> Fadhaa Abdul Sada Adhab Copyright (c) 2026 https://creativecommons.org/licenses/by/4.0 http://cmro.in/index.php/jcmro/article/view/1181 Sat, 23 May 2026 00:00:00 +0000